SUTURE-CLOSURE OMENTOPEXY VERSUS OMENTOPEXY ALONE IN REPAIR OF PERFORATED PEPTIC ULCER
Recruiting now · Not applicable
Conditions studied: Perforated Peptic Ulcer
In brief
The present study will be conducted to assess whether there is a direct benefit associated with modified-Graham's omentopexy (MGO), above and beyond the benefit associated with Graham's omentopexy (GO) in the treatment of perforated duodenal ulcers. We attempted to answer the question whether primary closure of the perforation in MGO will affect the outcome of surgery. Complication rates will be compared for the two alternative surgical procedures.
Key facts
- Study ID
- NCT06550856
- Run by
- Sohag University
- People needed
- 50
- Starts
- 2024-07-15
- Expected to finish
- 2025-05-01
- Last updated by the study team
- 2024-08-13
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All adult patients of both sexes with a clinical diagnosis of perforated peptic ulcer (gastric or duodenal) that are fit to undergo surgery.
You may not qualify if…
- 1. Patients with associated bleeding ulcer (additional steps are needed to control bleeding).
- Patients with associated pathology other than perforated peptic ulcer that needs surgical intervention.
Where it is running
- Sohag university Hospital — Sohag, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.